Roche Holding AG (RHHVF)
Roche Holding AG
Grenzacherstrasse 124
Basel 4058
Switzerland
41 61 688 11 11
https://www.roche.com
Sector(es): Healthcare
Industria: Drug Manufacturers - General
Empleados a tiempo completo: 103,605
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Dr. Severin Schwan Ph.D. | Executive Chairman | 8.19M | N/D | 1967 |
| Dr. Thomas Schinecker | Chief Executive Officer | 4.22M | N/D | 1975 |
| Dr. Alan Hippe | Chief Financial & Information Officer | 4.48M | N/D | 1967 |
| Dr. Bruno Eschli | Head of Investor Relations | N/D | N/D | N/D |
| Ms. Claudia Bockstiegel | General Counsel | N/D | N/D | 1964 |
| Ms. Pascale Schmidt | Chief Compliance Officer | N/D | N/D | 1973 |
| Ms. Barbara Schadler | Head of Group Communications | N/D | N/D | 1962 |
| Ms. Cristina A. Wilbur | Chief People Officer | 3.19M | N/D | 1967 |
| Dr. Nicolas Dunant | Head of Group Media Relations | N/D | N/D | N/D |
| Mr. Boris L. Zaitra | Head of Group Business Development and M&A | N/D | N/D | 1972 |
Descripción
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.
Gestión corporativa
La calificación ISS Governance QuickScore de Roche Holding AG a partir del 1 de mayo de 2024 es 8. Las puntuaciones principales son Auditoría: 4; Junta: 7; Derechos del accionista: 9; Compensación: 8.
